IP Library Granted Patent US 7,537,781
Granted Patent B2
US 7,537,781 · App. 10/777,801 · Granted May 26, 2009

Polymer-filler composites for controlled delivery of therapeutic agents from medical articles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,537,781
App. No.
10/777,801
Granted
May 26, 2009
Kind
B2
Abstract

A medical article comprising: (a) a therapeutic agent; and (b) a release region comprising (i) a polymer and (ii) a filler comprising inorganic platelet particles. Upon placement of such a medical article at a position on or within a patient, the release region regulates the rate of release of the therapeutic agent from the medical article to the patient. An example of a filler is one comprising inorganic platelet particles. Examples of medical articles include, for instance, drug delivery patches, and implantable or insertable medical devices. Also described are methods of releasing a therapeutic agent to a patient using such medical articles, and methods of making such medical articles.

Claims (26)

1. A medical article comprising:

(a) a therapeutic agent; and

(b) a release region comprising (i) a polymer and (ii) a filler comprising inorganic platelet particles, said release region regulating the rate of release of the therapeutic agent from the medical article upon placement of the medical article at a position on or within a patient, wherein said release region is selected from a release region that comprises said therapeutic agent and a release region that is disposed over a region that comprises said therapeutic agent.

2. The medical article of claim 1 , wherein said release region comprises said therapeutic agent.

3. The medical article of claim 1 , wherein said release region is disposed over a region that comprises said therapeutic agent.

4. The medical article of claim 1 , wherein said release region is disposed over at least a portion of a substrate.

5. The medical article of claim 4 , wherein said release region comprises said therapeutic agent.

6. The medical article of claim 4 , wherein said release region is disposed over a layer that comprises said therapeutic agent, which is further disposed over said substrate.

7. The medical article of claim 1 , wherein said medical article is adapted for implantation or insertion into a human body.

8. The medical article of claim 7 , wherein said medical article is adapted for implantation or insertion into the vasculature.

9. The medical article of claim 7 , wherein said medical article is selected from a catheter, a guide wire, a balloon, a filter, a stent, a stern graft, a vascular graft, a vascular patch, a shunt, and an intraluminal paving system.

10. The medical article of claim 7 , wherein said medical article is adapted for implantation or insertion into the esophagus, trachea, colon, biliary tract, urinary tract, prostate or brain.

11. The medical article of claim 1 , wherein said therapeutic agent is selected from an anti-thrombotic agent, an anti-proliferative agent, an anti-inflammatory agent, an anti-migratory agent, an agent affecting extracellular matrix production and organization, an antineoplastic agent, an anti-mitotic agent, an anesthetic agent, an anti-coagulant, a vascular cell growth promoter, a vascular cell growth inhibitor, a cholesterol-lowering agent, a vasodilating agent, and an agent that interferes with endogenous vasoactive mechanisms, or a combination of the same.

12. The medical article of claim 1 , wherein said wherein said filler comprises inorganic platelet particles having an aspect ratio greater than 100.

13. The medical article of claim 1 , wherein said wherein said filler comprises inorganic platelet particles having an aspect ratio greater than 1000.

14. The medical article of claim 1 , wherein said wherein said filler comprises exfoliated silicate platelet particles.

15. The medical article of claim 1 , wherein said filler comprises exfoliated silicate platelet particles selected from exfoliated bentonite platelet particles, exfoliated vermiculite platelet particles, exfoliated montmuorillonite platelet particles, exfoliated nontronite platelet particles, exfoliated beidellite platelet particles, exfoliated volkonskoite platelet particles, exfoliated hectorite platelet particles, exfoliated saponite platelet particles, exfoliated laponite platelet particles, exfoliated sauconite platelet particles, exfoliated magadiite platelet particles, exfoliated kenyaite platelet particles, exfoliated ledikite platelet particles, and mixtures thereof.

16. The medical article of claim 1 , wherein said filler comprises exfoliated vermiculite platelet particles.

17. The medical article of claim 1 , wherein said polymer comprises a poly(olefin) segment.

18. The medical article of claim 17 , wherein said polymer is a poly(olefin) homopolymer.

19. The medical article of claim 17 , wherein said polymer is a block copolymer comprising a poly(alkylene) segment.

20. The medical article of claim 1 , wherein said polymer comprises a poly(vinyl aromatic) segment.

21. The medical article of claim 20 , wherein said polymer is a block copolymer comprising a poly(vinyl aromatic) segment.

22. The medical article of claim 1 , wherein said polymer is a block copolymer comprising a poly(alkylene) segment and a poly(styrene) segment.

23. The medical article of claim 22 , wherein said polymer is a block copolymer comprising a poly(isobutylene) segment and a poly(styrene) segment.

24. The medical article of claim 23 , wherein said block polymer is a polystyrene-polyisobutylene-polystyrene triblock copolymer.

Assignments (1)
CHANGE OF NAME Recorded Nov 6, 2006
From: SCIMED LIFE SYSTEMS, INC.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 018505/0868 →